MORE ABOUT opioid and PRESCRIPTION DRUG ABUSE REDUCTION
CHMI seeks to cut prescription drug abuse deaths in half over the next five years – saving approximately 10,000 lives – through strategic partnerships that raise consumer and public awareness, advance business practice change, and mobilize communities.
Scaling Access to Naloxone
CHMI has brokered discounted pricing agreements with manufacturers of naloxone, an anti-opioid reversal agent, to provide a predictably affordable supply of naloxone to community groups, public safety organizations, and schools, creating a window of opportunity for the naloxone distribution field to scale over the next five years. CHMI has also partnered with Adapt Pharma, the American School Nurses Association, and a number of other partners to make FDA-approved naloxone NARCAN nasal spray available to every high school and college in the US, placing the potentially life-saving medicine in the hands of those who can intervene quickly during an overdose emergency. The spray is simple enough for people with no medical training to administer, and can be critical in saving the life of someone who has overdosed.
Johns Hopkins Working Group
In 2014, CHMI engaged Johns Hopkins University as a key research and content partner and, together, the Clinton Foundation and the Johns Hopkins Bloomberg School of Public Health (JHSPH) hosted a working meeting and public forum with the goal of taking a public health approach to the prescription drug misuse and abuse epidemic and using evidence to inform policy and practical action. Through this partnership and a series of multiple joint Town Halls, CHMI and JHSPH have steered a working group of stakeholders and decision makers to develop a consensus statement and guiding principles around the epidemic and to release a report outlining key recommendations needed to combat the epidemic across seven policy areas.
Building Communities of Support
In addition to the immediate and crucial impact of reducing deaths, CHMI aims to integrate naloxone access and implementation into a comprehensive prevention, intervention, treatment, and recovery model that is scalable and replicable across a diverse range of communities and populations. Currently, CHMI is working with partners and stakeholders from the opioid misuse and abuse prevention space to identify a new generation of communities primed not only for increased naloxone access, but a community-based model which incorporates a broad range of prevention and treatment goals.